We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+0.7%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$166B
AUM Growth
-$16.1B
Cap. Flow
-$15.1B
Cap. Flow %
-9.07%
Top 10 Hldgs %
10.62%
Holding
5,226
New
685
Increased
1,364
Reduced
1,922
Closed
756

Sector Composition

Rank Sector Weight
1 Technology 18.55%
2 Consumer Discretionary 8.97%
3 Financials 8.5%
4 Healthcare 8.44%
5 Industrials 7.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUR icon
301
Aurora
AUR
$12.4B
$121M 0.07%
29,260,125
-5,199,718
-15% -$23M
CRM icon
302
Salesforce
CRM
$139B
$121M 0.07%
645,704
-133,599
-17% -$27.7M
VZ icon
303
CALL
Verizon
VZ
$182B
$120M 0.07%
2,397,300
-1,308,500
-35% -$60.6M
ELV icon
304
Elevance Health
ELV
$82.9B
$119M 0.07%
405,992
-86,004
-17% -$28.3M
RDDT icon
305
PUT
Reddit
RDDT
$35.8B
$119M 0.07%
882,300
-59,500
-6% -$10.1M
DOCU
306
DocuSign
DOCU
$9.99B
$119M 0.07%
+2,501,812
New +$128M
NEE.PRS
307
NextEra Energy 7.299% Corporate Units
NEE.PRS
$2.15B
$118M 0.07%
2,081,000
+475,000
+30% +$26.2M
DOW icon
308
PUT
Dow Inc
DOW
$22B
$117M 0.07%
2,819,900
-758,600
-21% -$24.1M
DT icon
309
Dynatrace
DT
$13B
$117M 0.07%
3,160,367
+1,561,358
+98% +$59.7M
CVS icon
310
CVS Health
CVS
$137B
$116M 0.07%
1,617,522
+542,634
+50% +$41.8M
MRNA icon
311
CALL
Moderna
MRNA
$23.7B
$115M 0.07%
2,267,800
+401,200
+21% +$18.7M
JBS
312
JBS N.V.
JBS
$39.6B
$115M 0.07%
6,389,933
-815,695
-11% -$12.7M
LUNR icon
313
Intuitive Machines
LUNR
$2.35B
$114M 0.07%
6,162,811
+2,569,287
+71% +$47.4M
ASML icon
314
CALL
ASML
ASML
$692B
$114M 0.07%
86,100
+6,900
+9% +$9.46M
O icon
315
Realty Income
O
$60.6B
$113M 0.07%
1,850,345
+1,678,865
+979% +$105M
STX icon
316
PUT
Seagate
STX
$202B
$113M 0.07%
287,800
-22,100
-7% -$8.43M
NKE icon
317
PUT
Nike
NKE
$63.7B
$113M 0.07%
2,134,300
-81,000
-4% -$4.91M
TD icon
318
CALL
Toronto Dominion Bank
TD
$199B
$112M 0.07%
1,200,000
-527,500
-31% -$50.2M
PTCT icon
319
PTC Therapeutics
PTCT
$6.51B
$112M 0.07%
1,640,381
-104,610
-6% -$7.41M
VRTX icon
320
Vertex Pharmaceuticals
VRTX
$122B
$111M 0.07%
+248,960
New +$116M
RRX icon
321
Regal Rexnord
RRX
$13.7B
$111M 0.07%
593,462
+231,253
+64% +$43M
GWW icon
322
W.W. Grainger
GWW
$64.7B
$111M 0.07%
101,750
-152,893
-60% -$167M
ORCL.PRD
323
Oracle Corp Preferred Stock Series D
ORCL.PRD
$111M 0.07%
+2,421,500
New +$114M
KO icon
324
Coca-Cola
KO
$353B
$111M 0.07%
1,458,989
-1,841
-0.1% -$139K
Q
325
Qnity Electronics Inc
Q
$29.1B
$111M 0.07%
960,820
-2,623,376
-73% -$279M

Similar funds

D.E. Shaw & Co's Q1 2026 Portfolio in Review

As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

D.E. Shaw & Co withdrew a net $15.1B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.

  • D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
  • D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
  • D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
  • D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
  • D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
  • D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
  • D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.